Nexium (Esomeprazole)

Esomeprazole, the active ingredient in Nexium, is a proton pump inhibitor presented as an intravenous injection for intravenous use. It reduces gastric acid secretion and is used to treat conditions such as gastro‑oesophageal reflux disease, erosive esophagitis, prevention of NSAID‑induced gastric ulcers, and Zollinger‑Ellison syndrome in adult patients.

GNH USA supplies Nexium as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Nexium (esomeprazole) is a proton pump inhibitor used to manage acid‑related gastrointestinal disorders.

- Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of the esophageal mucosa. - Erosive esophagitis: accelerates ulcer healing and reduces recurrence. - Prevention of NSAID‑induced gastric ulcers: lowers the risk of ulcer formation in patients receiving NSAIDs. - Zollinger‑Ellison syndrome: controls gastric acid hypersecretion.

Common Side Effects: - Headache: mild to moderate pain often reported during therapy. - Diarrhea: loose stools that may occur early in treatment. - Nausea: sensation of unease or urge to vomit. - Abdominal pain: discomfort in the stomach region. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reactions (anaphylaxis): difficulty breathing, swelling, rash. - Clostridioides difficile infection: severe diarrhea with abdominal cramping. - Elevated liver enzymes: signs of hepatic stress. - Hypomagnesemia: low magnesium levels causing muscle cramps or arrhythmia. - Stevens‑Johnson syndrome: serious skin and mucous membrane disorder. - Cardiac arrhythmia: irregular heart rhythm, reported rarely.

Before initiating therapy, consider the following precautions: - Assess renal and hepatic function: adjust use if impairment is present. - Monitor serum magnesium: prolonged therapy may lower magnesium levels. - Use with caution in patients with known hypersensitivity to PPIs. - Evaluate for potential drug interactions, especially with clopidogrel and antiretrovirals. - Avoid in patients with severe liver disease unless benefits outweigh risks. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Esomeprazole may interact with several medications; review the following:

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect. - Atazanavir: decreased absorption and efficacy. - HIV protease inhibitors (e.g., ritonavir): altered metabolism leading to reduced drug levels. - Warfarin: enhanced anticoagulant effect, increased bleeding risk.

Moderate Interactions (Monitor Closely): - Digoxin: increased serum concentrations. - Methotrexate: reduced clearance, potential toxicity. - Phenytoin: decreased anticonvulsant efficacy.